Want to see MCK full AI Analyst Report?

McKesson (MCK) Stock Forecast & Price Target

2,325 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

MCK Analyst Ratings

Strong Buy

12 Buy

3 Hold

0 Sell

Based on 15 analysts giving stock ratings to

McKesson

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

MCK Stock 12 Month Forecast

Average Price Target

$996.86

▲(10.14% Upside)

Based on 15 Wall Street analysts offering 12 month price targets for McKesson in the last 3 months. The average price target is $996.86 with a high forecast of $1,200.00 and a low forecast of $845.00. The average price target represents a 10.14% change from the last price of $905.09.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"733":"$733","850":"$850","967":"$967","1084":"$1,084","1201":"$1,201"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1200,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.20K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":996.8571428571429,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$996.86</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":845,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$845.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[733,850,967,1084,1201],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,898.82,921.9876923076923,945.1553846153846,968.323076923077,991.4907692307693,1014.6584615384616,1037.8261538461538,1060.993846153846,1084.1615384615384,1107.329230769231,1130.4969230769232,1153.6646153846154,1176.8323076923077,{"y":1200,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,898.82,906.3613186813187,913.9026373626374,921.4439560439561,928.9852747252747,936.5265934065934,944.0679120879122,951.6092307692309,959.1505494505495,966.6918681318682,974.2331868131869,981.7745054945055,989.3158241758242,{"y":996.8571428571429,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,898.82,894.6800000000001,890.5400000000001,886.4000000000001,882.26,878.12,873.98,869.84,865.7,861.5600000000001,857.42,853.28,849.14,{"y":845,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":762.079,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":808.158,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":854.324,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":817.834,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":843.975,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":988.804,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":870.431,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":812.257,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":734.039,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":767.244,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":855.28,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":906.77,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":898.82,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$1,200

Average Price Target$996.86

Lowest Price Target$845.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Kevin Caliendo

UBS

$1,080→$1,200

Buy

32.58%

Upside

Reiterated

10/16/26

Analysts Offer Insights on Healthcare Companies: McKesson (NYSE: MCK), Crescent Biopharma (NASDAQ: CBIO) and Glaukos (NYSE: GKOS)

Unknown Analyst

Leerink Partners

Not Ranked

Leerink Partners

$1,030→$1,070

Buy

18.22%

Upside

Reiterated

10/07/26

McKesson (MCK) Gets a Buy from Leerink Partners

Erin Wright

Morgan Stanley

$977

Buy

7.95%

Upside

Reiterated

10/06/26

McKesson: Buy Rating Reiterated as Option Care Stake Strengthens Home Infusion Strategy; $977 Price Target Maintained

George Hill

Deutsche Bank

$913

Buy

0.87%

Upside

Reiterated

10/06/26

Deutsche Bank Remains a Buy on McKesson (MCK)

Ryan Halsted

RBC Capital

$845

Hold

-6.64%

Downside

Reiterated

10/06/26

RBC Capital Remains a Hold on McKesson (MCK)

Elizabeth Anderson CFA

Evercore ISI

$1,000

Buy

10.49%

Upside

Reiterated

10/06/26

Analysts Are Bullish on Top Healthcare Stocks: Alector (ALEC), McKesson (MCK)

Allen Lutz

Bank of America Securities

$1,050

Buy

16.01%

Upside

Reiterated

10/05/26

McKesson: Strategic Specialty Expansion Supports Unchanged $1,050 Price Target and Buy Rating

Ryan Daniels

William Blair

―

Buy

―

Reiterated

10/05/26

Analysts Are Bullish on Top Healthcare Stocks: McKesson (MCK), Opus Genetics (IRD)

Glen Santangelo

Barclays

$925→$1,000

Buy

10.49%

Upside

Reiterated

08/18/26

Barclays Sticks to Its Buy Rating for McKesson (MCK)

Stephen Baxter

Wells Fargo

$812→$933

Hold

3.08%

Upside

Assigned

08/11/26

Wells Fargo Releases a Hold Rating on McKesson (MCK)

Lisa Gill

J.P. Morgan

$1,042

Buy

15.13%

Upside

Reiterated

08/10/26

McKesson (MCK) Gets a Buy from J.P. Morgan

Daniel Grosslight

Citi

$1,000

Buy

10.49%

Upside

Reiterated

08/10/26

Citi Keeps Their Buy Rating on McKesson (MCK)

Eric Coldwell

Robert W. Baird

$955→$1,015

Buy

12.14%

Upside

Reiterated

08/06/26

McKesson price target raised to $1,015 from $955 at BairdMcKesson price target raised to $1,015 from $955 at Baird

Charles Rhyee

TD Cowen

$989→$1,006

Buy

11.15%

Upside

Assigned

08/06/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Steven Valiquette

Mizuho Securities

$885→$905

Hold

>-0.01%

Downside

Reiterated

08/05/26

McKesson price target raised to $905 from $885 at MizuhoMcKesson price target raised to $905 from $885 at Mizuho

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Kevin Caliendo

UBS

$1,080→$1,200

Buy

32.58%

Upside

Reiterated

10/16/26

Analysts Offer Insights on Healthcare Companies: McKesson (NYSE: MCK), Crescent Biopharma (NASDAQ: CBIO) and Glaukos (NYSE: GKOS)

Unknown Analyst

Leerink Partners

Not Ranked

Leerink Partners

$1,030→$1,070

Buy

18.22%

Upside

Reiterated

10/07/26

McKesson (MCK) Gets a Buy from Leerink Partners

Erin Wright

Morgan Stanley

$977

Buy

7.95%

Upside

Reiterated

10/06/26

McKesson: Buy Rating Reiterated as Option Care Stake Strengthens Home Infusion Strategy; $977 Price Target Maintained

George Hill

Deutsche Bank

$913

Buy

0.87%

Upside

Reiterated

10/06/26

Deutsche Bank Remains a Buy on McKesson (MCK)

Ryan Halsted

RBC Capital

$845

Hold

-6.64%

Downside

Reiterated

10/06/26

RBC Capital Remains a Hold on McKesson (MCK)

Elizabeth Anderson CFA

Evercore ISI

$1,000

Buy

10.49%

Upside

Reiterated

10/06/26

Analysts Are Bullish on Top Healthcare Stocks: Alector (ALEC), McKesson (MCK)

Allen Lutz

Bank of America Securities

$1,050

Buy

16.01%

Upside

Reiterated

10/05/26

McKesson: Strategic Specialty Expansion Supports Unchanged $1,050 Price Target and Buy Rating

Ryan Daniels

William Blair

―

Buy

―

Reiterated

10/05/26

Analysts Are Bullish on Top Healthcare Stocks: McKesson (MCK), Opus Genetics (IRD)

Glen Santangelo

Barclays

$925→$1,000

Buy

10.49%

Upside

Reiterated

08/18/26

Barclays Sticks to Its Buy Rating for McKesson (MCK)

Stephen Baxter

Wells Fargo

$812→$933

Hold

3.08%

Upside

Assigned

08/11/26

Wells Fargo Releases a Hold Rating on McKesson (MCK)

Lisa Gill

J.P. Morgan

$1,042

Buy

15.13%

Upside

Reiterated

08/10/26

McKesson (MCK) Gets a Buy from J.P. Morgan

Daniel Grosslight

Citi

$1,000

Buy

10.49%

Upside

Reiterated

08/10/26

Citi Keeps Their Buy Rating on McKesson (MCK)

Eric Coldwell

Robert W. Baird

$955→$1,015

Buy

12.14%

Upside

Reiterated

08/06/26

McKesson price target raised to $1,015 from $955 at BairdMcKesson price target raised to $1,015 from $955 at Baird

Charles Rhyee

TD Cowen

$989→$1,006

Buy

11.15%

Upside

Assigned

08/06/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Steven Valiquette

Mizuho Securities

$885→$905

Hold

>-0.01%

Downside

Reiterated

08/05/26

McKesson price target raised to $905 from $885 at MizuhoMcKesson price target raised to $905 from $885 at Mizuho

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AXGNAxoGen

MDWDMediwound

OCULOcular Therapeutix

OVIDOvid Therapeutics

ZYMEZymeworks

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering McKesson

3 Months

Erin WrightMorgan Stanley

Success Rate

21/25 ratings generated profit

Average Return

+7.51%

Copying Erin Wright's trades and holding each position for 3 Months would result in 84.00% of your transactions generating a profit, with an average return of +7.51% per trade.

1 Year

Elizabeth Anderson CFAEvercore ISI

Success Rate

27/27 ratings generated profit

Average Return

+28.86%

Copying Elizabeth Anderson CFA's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +28.86% per trade.

2 Years

Elizabeth Anderson CFAEvercore ISI

Success Rate

27/27 ratings generated profit

Average Return

+50.16%

Copying Elizabeth Anderson CFA's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +50.16% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MCK Analyst Recommendation Trends

Rating

Jun 26

Jul 26

Aug 26

Sep 26

Oct 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, MCK has received 25 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. MCK average Analyst price target in the past 3 months is 996.86.

Each month's total comprises the sum of three months' worth of ratings.

MCK Financial Forecast

MCK Earnings Forecast

Next quarter’s earnings estimate for MCK is $10.72 with a range of $10.53 to $10.91. The previous quarter’s EPS was $9.93. MCK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year MCK has Performed in-line its overall industry.

MCK Sales Forecast

Next quarter’s sales forecast for MCK is $109.86B with a range of $108.83B to $110.79B. The previous quarter’s sales results were $105.38B. MCK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year MCK has Performed in-line its overall industry.

MCK Stock Forecast FAQ

What is MCK’s average 12-month price target, according to analysts?

Based on analyst ratings, Mckesson Corp.’s 12-month average price target is 996.86.

What is MCK’s upside potential, based on the analysts’ average price target?

Mckesson Corp. has 10.14% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is MCK a Buy, Sell or Hold?

Mckesson Corp. has a consensus rating of Strong Buy which is based on 12 buy ratings, 3 hold ratings and 0 sell ratings.

What is Mckesson Corp.’s price target?

The average price target for Mckesson Corp. is 996.86. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $1,200.00 ,the lowest forecast is $845.00. The average price target represents 10.14% Increase from the current price of $905.09.

What do analysts say about Mckesson Corp.?

Mckesson Corp.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Streets Analysts.

How can I buy shares of MCK?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

McKesson (MCK) Stock Forecast & Price Target

MCK Analyst Ratings

MCK Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering McKesson

MCK Analyst Recommendation Trends

MCK Financial Forecast

MCK Earnings Forecast

MCK Sales Forecast

MCK Stock Forecast FAQ

Detailed List of Analyst Forecasts